Klik på en miniature for at gå til Google Books
Indlæser... The Antidote: Inside the World of New Pharma (udgave 2014)af Barry Werth
Værk informationThe Antidote: Inside the World of New Pharma af Barry Werth
Ingen Indlæser...
Bliv medlem af LibraryThing for at finde ud af, om du vil kunne lide denne bog. Der er ingen diskussionstråde på Snak om denne bog. Great follow up to his first book, The Billion Dollar Molecule. For me origin stories are more fascinating than the "maintenance" story. This book "feels" right with respect to the topic - its frantic prose matches the pace of science - many fits and starts - especially for a company that's 1. invested in beating out the competition with a tighter budget, 2. maturing to a proper drug producing pharmaceutical business. The investigative reporting is extremely thorough and if you're not into the science or business, it'll fail to appeal to you. For me it was too much on the financial side of things - constant monitoring of stock prices - I would have to have a better grasp of the business side to appreciate it. I liked the last part, which was quite revealing and transparent about the drug approval process from the trenches. ( ) ingen anmeldelser | tilføj en anmeldelse
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success. The $325-billion-a-year pharmaceutical business is America's toughest and one of its most profitable. It is riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades. Ingen biblioteksbeskrivelser fundet. |
Aktuelle diskussionerIngenPopulære omslag
Google Books — Indlæser... GenrerMelvil Decimal System (DDC)338.4Social sciences Economics Production Secondary industries and servicesLC-klassificeringVurderingGennemsnit:
Er det dig?Bliv LibraryThing-forfatter. |